RE: Eyes12 Mar 2025 11:47
Pumpky the only thing that doesn't add up is your ability to read.
'Roquefort Therapeutics will receive circa 24% from any successful trade sale proceeds, which if the Phase 1 trial is successful, this 24% is projected to be worth up to US$50M (gross) based on similar phase 1 trade sales.'